Catalent and AAPS Announce Winners of Annual Academic Competition - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Catalent and AAPS Announce Winners of Annual Academic Competition



The Catalent Applied Drug Delivery Institute and the American Association of Pharmaceutical Scientists (AAPS), reported the winners of their “Global Academic Competition for Life Science Leaders of Tomorrow.” Chosen from US and international universities with graduate programs in pharmaceutical science, the five winners were Maren Preis, University of Dusseldorf, “Regulatory Challenges & Available Dosage Forms”; Prachi Shah, St. Johns University, “Double Emulsions: Scope and Attempts”; Nilesh Gupta, Texas Tech University, “Challenges in Developing Inhalation Technology: Right Particle Size and Device Selection”; Tannaz Ramezanli, Rutgers University, “Stem Cells as Novel Carriers for Cancer Therapy”; and Emrah Ilker Ozay, UMass Amherst, “Slipping through the blood brain barrier with cell penetrating peptide mimics.”

Each winner will receive a cash prize of $2,000 and annual membership to the AAPS. The annual competition aims to identify emerging scientific talent, foster drug delivery education, and reward academic excellence. Competition entries consisted of original review articles addressing topics such as drug development, delivery technologies, improving therapeutic profiles and bioavailability, preformulation, and pediatric drugs.

Source: Catalent Applied Drug Delivery Institute

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes

Click here